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OA synovium contains subpopulations of mesenchymal progenitor 
cells with osteogenic and chondrogenic differentiation capacity
S. Fickert1, J. Fiedler2, R. Brenner3;
1Department Of Orthopaedic Surgery, University Hospital of 
Mannheim, Faculty of Medicine of the University of Heidelberg, 
Mannheim, Germany, 2Division Of Biochemistry Of Joint And 
Connective Tissue Diseases, University of Ulm, Ulm, Germany, 
3Division Of Biochemistry Of Joint And Connective Tissue Diseases, 
university of Ulm, ulm, Germany
Purpose: *EFOUJ¾DBUJPORVBOUJ¾DBUJPOBOEJTPMBUJPOPGTVCQPQVMBUJPOT
with characteristics of mesenchymal progenitor cells (MPC) from the 
synovial membrane (SM) from patients with osteoarthritis (OA). 
Methods and Materials: Cells from the SM of patients with end stage 
OA who underwent total knee joint replacement were enzymatically 
JTPMBUFE 0OF BMJRVPU XBT EJSFDUMZ BOBMZ[FE CZ ¿VPSFTDFODF
automated cell sorting (FACS) using various combinations of surface 
markers of bone marrow MPC (CD9, CD44, CD54, CD90, and CD166). 
Remaining cells were cultivated on plastic, expanded over several 
passages, analyzed by FACS again and tested for their osteo- and 
chondrogenic potential. The differentiation was analyzed by immuno-
/histochemistry and by RT-PCR for the expression of lineage related 
marker genes. 
Results: Using FACS analysis we could show that the relative 
proportion of subpopulations expressing triplicate combinations 
of CD9, CD44, CD54, CD90 and CD166 in the SM from OA patients 
varies between 3 and 10%. Upon cultivation their relative amount 
markedly increased to values between 24 and 48%. Within the 
heterogeneous cell populations it was possible to induce osteogenic 
and chondrogenic differentiation. Initial sorting for CD9/CD90/CD166 
triplicate positive cells proved that this subpopulation contains 
cells with multipotency for mesenchymal differentiation and thus 
characteristics of MPC. 
Conclusions: Our results show that SM from OA patients contains 
cells that express typical combinations of MPC surface markers and 
have the potency of osteogenic and chondrogenic differentiation. 
Their relative enrichment during in vitro cultivation and the possibility 
of cell sorting to get more homogenous populations offer interesting 
perspectives for possible future therapeutic applications. 
P113
Chemokines recruit human mesenchymal progenitors and are 
candidates for regenerative Tissue Engineering approaches
K. Neumann1, M. Endres2, J. Ringe3, M. Sittinger3, C. Kaps4;
1TransTissueTechnologies GmbH, Berlin, Germany, 2R&D,
TransTissueTechnologies GmbH, Berlin, Germany, 3Tissue
Engineering Laboratory, Charité-University Medicine Berlin, Berlin, 
Germany, 4TransTissue Technologies GmbH, Berlin, Germany
Purpose: The aim of this study was to analyze the potential of 
chemokines to attract mesenchymal progenitor cells (MPC) derived 
from bone marrow. Chemokines are attractive candidates for cell 
free Tissue Engineering approaches, thus guiding progenitors to the 
defect site. 
Methods and Materials: Human MPC were isolated as well as 
cultivated under standard conditions and characterized using FACS 
UFDIOJRVF5IFDIFNPLJOFSFDFQUPSQSP¾MFPG.1$XBTEFUFSNJOFE
by real time gene expression analysis and immunohistochemistry. 
Recruitment of MPC by selected candidates was examined using 
the ChemoTx® System (Neuroprobe), in different concentrations (1-
1000nM) in each essay. 
Results: Human MPC showed a robust pattern of typical cell surface 
antigens like e.g. SH-2, SH-3 and CD90 and expressed a variety 
of chemokine receptors. Amongst others, MPC expressed the 
chemokine receptors CXCR1, CXCR2 and CCR2. These receptors bind 
to the chemokine ligands SDF-1, IL-8 and MCP-1. 96 well chemotaxis 
assays demonstrated that SDF-1 and IL-8 recruited MPC dose 
dependently, whereas MCP-1 did not recruit at all. 
Conclusions: Chemokines recruit MPC and therefore are promising 
candidates for cell free Tissue Engineering approaches, guiding 
multipotential progenitors to sites of injured tissue. 
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Effect of three-dimensional expansion and cell seeding density on 
the cartilage-forming capacity of human articular chondrocytes in 
type II collagen sponges.
S. Francioli1, C. Candrian1, K. Martin2, M. Heberer3, I. Martin3,
A. Barbero4;
1Deparment Of Surgery And Of Research, University-Hospital, Basel, 
Switzerland, 2Division Biomaterials, Geistlich Pharma AG, Wolhusen, 
Switzerland, 3Department Of Surgery And Of Research, University 
Hospital Basel, Basel, Switzerland, 4Deparment Of Surgergery And 
Research, University Hospital Basel, Basel, Switzerland
Purpose: We investigated whether the quality of cartilaginous tissues 
generated in vitro by human articular chondrocytes (HAC) on collage-II 
sponges can be enhanced by direct expansion of HAC on the biomaterial, 
as compared to standard monolayer on plastic, or by increasing cell 
seeding density. 
Methods and Materials: HAC were isolated from the cartilage biopsies 
of three different patients. Cell constructs were generated by: HAC 
expansion directly on collagen-II sponges (Chondrocell, Geistlich, CH) for 
4 doublings (expansion time: 9days; density yielded: 35x106cells/cm3)
(group 1); HAC expansion in monolayer for 4 doublings (expansion time: 
6days) and then seeding on the sponges at 35x106cells/cm3 (group 2); 
HAC expansion in monolayer for 8 doublings (expansion time: 12days) 
and then seeding on the sponges at 35x106 (group 3) or 70x106cells/cm3
(group 4). Constructs were then cultured for 4weeks in medium promoting 
chondrogenesis. The generated tissues were assessed histologically 
(Safranin-O) and biochemically (glycosaminoglycans –GAG– and DNA). 
Results: HAC expanded in collagen-II sponges (group 1) or monolayer 
	HSPVQ
GPSEPVCMJOHTHFOFSBUFEUJTTVFXJUI¾CSPCMBTUJDBQQFBSBODF
and low GAG/DNA. Also HAC expanded in monolayer for 8 doublings 
generated tissue with poor quality when seeded at 35x106cells/cm3
(group 3). However, when seeded at 70x106cells/cm3 (group 4), HAC 
generated hyaline-like cartilaginous tissues intensely stained for GAG 
and containing 2.2-fold more GAG/DNA. 
Conclusions: High cell seeding density is a crucial factor for chondrogenesis 
of HAC in collagen-II sponges. Direct expansion on collagen-II sponges 
did not enhance the quality of the resulting cartilaginous tissues possibly 
CFDBVTFJUEJEOPUBMMPXUPSFBDIBTVG¾DJFOUDFMMEFOTJUZ
P115
IGF-1 gene-supplemented type II collagen scaffolds for 
mesenchymal stem cell-driven chondrogenesis in vitro
T. Gotterbarm1, J. Niska2, R.M. Capito3, S.M. Vickers4, M. Spector5;
1Department Of Orthopaedics, University of Heidelberg, Heidelberg, 
Germany, 2Va Boston Healthcare System, Harvard Medical School, 
Boston, MA, United States of America, 3Materials Science & 
Engineering, Massachusetts Institute of Technology, Cambridge, MA, 
United States of America, 4Mechanical Engineering, Massachusetts 
Institute of Technology, Cambridge, Massachusetts, United States 
of America, 5Orthopaedic Surgery, Brigham and Women‘s Hospital, 
Harvard Medical School, Boston, United States of America
Purpose: The purpose of this study was to develop an IGF-1 gene-
supplemented type II collagen scaffold to stimulate stem cell-driven 
chondrogenesis in vitro. 
Methods and Materials: Highly porous scaffolds were fabricated 
by ramp-freeze-drying and dehydrothermal treatment of a type II 
collagen slurry (Geistlich Biomaterials, Wolhusen, Switzerland). 
IGF-1 plasmid DNA was complexed to a lipid-mediated transfection 
reagent and incorporated in the scaffolds. Bone marrow-derived 
mesenchymal stem cells were isolated from six Spanish goats, 
subcultured separately (to P2) and seeded onto the collagen sponges 
(4 million). Scaffolds with or without pIGF-1 were cultured for 14 days 
in serum-free chondrogenic media containing either rhTGF-ȕ1 (10ng/
ml) or with additional rhIGF-1 (100ng/ml). At 3 and 14 days DNA and 
GAG content was biochemically assessed and the scaffold diameter 
was measured (n=6). Scaffolds were stained for hematoxylin/eosin, 
and Safranin-O/Fast green for GAG. 
Results: All scaffolds showed a comparable amount of cell-mediated 
DPOUSBDUJPO"UEBZTBTJHOJ¾DBOUMZMPXFSBNPVOUPG%/"XBTGPVOE
in gene-activated scaffolds (p<0.04), perhaps related to impaired cell 
BEIFTJPO"GUFSEBZTPGDVMUVSFBMMHSPVQTEJTQMBZFEBTJHOJ¾DBOU
increase of GAG deposition. pIGF-1 supplementation exhibited 
TJHOJ¾DBOUMZ IJHIFS WBMVFT PG ("(%/" DPNQBSFE UP DPOUSPMT
Histochemical staining with Safranin-O/Fast Green was consistent 
with the biochemical data. 
Conclusions: Our data suggest that transient incorporation of IGF-
1 plasmid DNA into type II collagen scaffolds stimulates stem cell-
driven chondrogenesis. Gene-supplemented scaffolds may be of 
value as implants to improve the outcome of selected cartilage 
repair procedures.
